Morning Movers
Watch us on YouTube Live at 8:30AM EST

Chinese Stocks – Alibaba Group shares are down more than 1% in early trading on a FT report suggesting its financial affiliate Ant Group is again under scrutiny. Regulators want to break up Alipay, which is China’s biggest payments app with more than a billion users, according to the report. Elsewhere, BIDU has opened the first robo-taxi ride hailing service in Shanghai with the Apollo Go Ride-Hailing Platform. BABA, BIDU, JD, PDD

SPCE. NY -3.30%
Virgin Galactic – Lower after flagging a possible new delay Friday to its first commercial research mission with the Italian Air Force to mid-October. The company attributes the delay to the pending resolution of the U.S. Federal Aviation Administration (FAA) probe; adds a third-party supplier warned of a potential manufacturing defect in a component of the flight control system. The mission was initially set for late-September or early-October.

AAPL.NQ 0.94%
Apple Inc – Led the selloff for the overall market late Friday and are looking to stabilized this morning. The stock lost about $84 billion in market capitalization following a U.S. judge’s mixed decision on the iPhone maker’s fight with “Fortnite” game maker Epic Games last week. The court issued a permanent injunction that would let app developers to route its players to alternative platforms to make payments, allowing them to avoid Apple’s 30% App Store fees.

Squeeze Stocks – AMC shares are back among the most active in premarket trading this morning up nearly 3% last. BBIG, ATER, SPRT shares are also all bouncing back after heavy selling into the close on Friday. BBIG, ATER, SPRT, AMC

COIN.NQ -0.27%
Coinbase Global – Coinbase announces proposed private offering of $1.5 billion of senior notes for general corporate purposes including product development and potential m&a.

DVAX.NQ -9.91%
Dynavax Technologies – The company’s partner for Covid-19 vaccine gets termination notice from UK Government. The British government ends its COVID-19 vaccine supply deal with French vaccine maker Valneva SE, alleging a breach of obligations that Valneva denies.

LPTX.NQ 39.73%
Leap Therapeutics – To present new data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress.

MDXG.NQ -51.06%
MiMedx Group – Reports Top-Line data from two late-stage Musculoskeletal trials with proprietary amniotic tissue technology.

Leave a Reply

Your email address will not be published.